Karolin Behringer

2.8k total citations
52 papers, 1.6k citations indexed

About

Karolin Behringer is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Karolin Behringer has authored 52 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pathology and Forensic Medicine, 20 papers in Pulmonary and Respiratory Medicine and 17 papers in Oncology. Recurrent topics in Karolin Behringer's work include Lymphoma Diagnosis and Treatment (42 papers), Lung Cancer Treatments and Mutations (20 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Karolin Behringer is often cited by papers focused on Lymphoma Diagnosis and Treatment (42 papers), Lung Cancer Treatments and Mutations (20 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Karolin Behringer collaborates with scholars based in Germany, Austria and Switzerland. Karolin Behringer's co-authors include Volker Diehl, Andreas Engert, Peter Borchmann, Michael Fuchs, Teresa Halbsguth, Thorsten Reineke, L. Wildt, Beate Klimm, Dennis A. Eichenauer and Helen Goergen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.

In The Last Decade

Karolin Behringer

49 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karolin Behringer Germany 21 828 720 565 379 325 52 1.6k
Teresa Halbsguth Germany 15 485 0.6× 443 0.6× 216 0.4× 126 0.3× 181 0.6× 25 971
Helen Goergen Germany 19 774 0.9× 524 0.7× 179 0.3× 85 0.2× 275 0.8× 41 1.1k
B. W. Hancock United Kingdom 16 434 0.5× 487 0.7× 378 0.7× 79 0.2× 148 0.5× 52 1.3k
Silvia Franceschetti Italy 17 751 0.9× 366 0.5× 139 0.2× 126 0.3× 161 0.5× 47 1.3k
G. Schellong Germany 25 1.2k 1.4× 595 0.8× 1.2k 2.2× 86 0.2× 290 0.9× 106 2.6k
F Deméocq France 22 234 0.3× 312 0.4× 424 0.8× 81 0.2× 202 0.6× 78 1.5k
H.H. Lucraft United Kingdom 18 409 0.5× 350 0.5× 134 0.2× 68 0.2× 182 0.6× 37 1.0k
Irène Biasoli Brazil 19 712 0.9× 626 0.9× 85 0.2× 56 0.1× 170 0.5× 44 1.2k
Merlın Hamre United States 18 212 0.3× 425 0.6× 209 0.4× 53 0.1× 303 0.9× 29 1.1k
J. Nicholls United Kingdom 17 155 0.2× 245 0.3× 177 0.3× 483 1.3× 497 1.5× 30 1.8k

Countries citing papers authored by Karolin Behringer

Since Specialization
Citations

This map shows the geographic impact of Karolin Behringer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karolin Behringer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karolin Behringer more than expected).

Fields of papers citing papers by Karolin Behringer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karolin Behringer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karolin Behringer. The network helps show where Karolin Behringer may publish in the future.

Co-authorship network of co-authors of Karolin Behringer

This figure shows the co-authorship network connecting the top 25 collaborators of Karolin Behringer. A scholar is included among the top collaborators of Karolin Behringer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karolin Behringer. Karolin Behringer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olíva, Esther Natalie, Tatyana Ionova, Edward Laane, et al.. (2024). Patient-reported outcomes in Hodgkin lymphoma trials: a systematic review. Frontiers in Oncology. 14. 1353101–1353101. 1 indexed citations
2.
3.
Bröckelmann, Paul J., Peter Herhaus, Julia Meißner, et al.. (2023). Fertility and Gonadal Function after First-Line Treatment with Nivolumab-AVD in Hodgkin Lymphoma Patients: An Analysis from the Phase II GHSG Nivahl Trial. Blood. 142(Supplement 1). 4456–4456.
4.
Bröckelmann, Paul J., Peter Herhaus, Julia Meißner, et al.. (2023). Quality of Life with Nivolumab and AVD First-Line Treatment in Hodgkin Lymphoma: Patient-Reported Outcomes from the Phase II GHSG Nivahl Trial. Blood. 142(Supplement 1). 1710–1710.
5.
Rosenbrock, Johannes, Horst Mueller, Karolin Behringer, et al.. (2021). Involved Site Radiotherapy Extends Time to Premature Menopause in Infra-Diaphragmatic Female Hodgkin Lymphoma Patients – An Analysis of GHSG HD14- and HD17-Patients. Frontiers in Oncology. 11. 658358–658358. 6 indexed citations
6.
Eichenauer, Dennis A., Annette Plütschow, Stefanie Kreissl, et al.. (2017). Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group. The Lancet Oncology. 18(12). 1680–1687. 70 indexed citations
7.
Goergen, Helen, H. Mueller, Stefanie Kreissl, et al.. (2016). PATIENT PREFERENCES - SURVEY OF HODGKIN LYMPHOMA SURVIVORS ON TREATMENT-ASSOCIATED BURDEN AND SIDE EFFECTS. Kölner Universitäts PublikationsServer (Universität zu Köln). 3 indexed citations
8.
Eichenauer, Dennis A., Annette Plütschow, Michael Fuchs, et al.. (2015). Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group. Journal of Clinical Oncology. 33(26). 2857–2862. 52 indexed citations
9.
Rancea, Michaela, Andreas Engert, Bastian von Tresckow, et al.. (2013). Hodgkin’s Lymphoma in Adults. Deutsches Ärzteblatt international. 110(11). 177–83, 183e1. 19 indexed citations
10.
Böll, Boris, Annette Plütschow, Michael Fuchs, et al.. (2013). German Hodgkin Study Group Phase I Trial Of Doxorubicin, Vinblastine, Dacarbazine, and Lenalidomide (AVD-Rev) For Older Hodgkin Lymphoma Patients. Blood. 122(21). 3054–3054. 8 indexed citations
11.
Behringer, Karolin, Indra Thielen, Horst Mueller, et al.. (2012). Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial. Annals of Oncology. 23(7). 1818–1825. 63 indexed citations
12.
13.
Sieniawski, Michal, Thorsten Reineke, Andreas Josting, et al.. (2008). Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials. Annals of Oncology. 19(10). 1795–1801. 73 indexed citations
14.
Vehreschild, Jörg Janne, Karsten Krüger, Oliver Kurzai, et al.. (2006). Salvage Therapy of Refractory Chronic Disseminated Candidiasis in a Patient with Acute Myeloid Leukaemia and Secondary Prophylaxis During Allogeneic Stem Cell Transplantation. Mycoses. 49(s1). 42–47. 9 indexed citations
15.
Diehl, Volker & Karolin Behringer. (2006). Could BEACOPP Be the New Standard for the Treatment of Advanced Hodgkin's Lymphoma?. Cancer Investigation. 24(4). 461–465. 7 indexed citations
16.
Draube, Andreas, Karolin Behringer, & Volker Diehl. (2006). German Hodgkin's Lymphoma Study Group Trials: Lessons from the Past and Current Strategies. Clinical Lymphoma & Myeloma. 6(6). 458–468. 7 indexed citations
17.
Diehl, Volker & Karolin Behringer. (2006). Could BEACOPP Be the New Standard for the Treatment of Advanced Hodgkin's Lymphoma (HL)?. Cancer Investigation. 24(7). 713–717. 17 indexed citations
18.
Reineke, Thorsten, Andreas Josting, Hans Konrad Müller‐Hermelink, et al.. (2005). Lymphocyte‐predominant and classical Hodgkin's lymphoma – comparison of outcomes. European Journal Of Haematology. 75(s66). 106–110. 20 indexed citations
19.
Borchmann, Peter, Karolin Behringer, Andreas Josting, et al.. (2005). Sekundärneoplasien nach erfolgreicher Primärtherapie des malignen Hodgkin-Lymphoms. Der Pathologe. 27(1). 47–52. 2 indexed citations
20.
Engert, Andreas, Volker Diehl, Andreas Josting, & Karolin Behringer. (2004). Moderne Pharmakotherapie des Morbus Hodgkin. Der Internist. 45(1). 93–101. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teresa Halbsguth Breakdown of academic impact, for papers by Helen Goergen Breakdown of academic impact, for papers by B. W. Hancock Breakdown of academic impact, for papers by Silvia Franceschetti Breakdown of academic impact, for papers by G. Schellong Breakdown of academic impact, for papers by F Deméocq Breakdown of academic impact, for papers by H.H. Lucraft Breakdown of academic impact, for papers by Irène Biasoli Breakdown of academic impact, for papers by Merlın Hamre Breakdown of academic impact, for papers by J. Nicholls
Rankless by CCL
2026